PILMAN » transparency http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Drug Prescription In Generic Names Only, No Branded Generics http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/?utm_source=rss&utm_medium=rss&utm_campaign=drug-prescription-in-generic-names-only-no-branded-generics http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/#comments Sun, 20 Aug 2023 07:24:49 +0000 Tapan Ray http://www.tapanray.in/?p=10812 Continue reading →]]> http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/feed/ 0 Self-made Barriers To Business Transparency Impacting Drug Access http://www.tapanray.in/self-made-barriers-to-business-transparency-impacting-drug-access/?utm_source=rss&utm_medium=rss&utm_campaign=self-made-barriers-to-business-transparency-impacting-drug-access http://www.tapanray.in/self-made-barriers-to-business-transparency-impacting-drug-access/#comments Mon, 05 Aug 2019 00:00:30 +0000 Tapan Ray http://www.tapanray.in/?p=9655 Continue reading →]]> http://www.tapanray.in/self-made-barriers-to-business-transparency-impacting-drug-access/feed/ 0 How Creative Is Pharma Industry? http://www.tapanray.in/how-creative-is-pharma-industry/?utm_source=rss&utm_medium=rss&utm_campaign=how-creative-is-pharma-industry http://www.tapanray.in/how-creative-is-pharma-industry/#comments Mon, 15 Apr 2019 00:00:57 +0000 Tapan Ray http://www.tapanray.in/?p=9482 Continue reading →]]> http://www.tapanray.in/how-creative-is-pharma-industry/feed/ 0 Innovative ‘Medicines Too Damn Expensive’: Health Risk For Billions of People http://www.tapanray.in/innovative-medicines-too-damn-expensive-health-risk-for-billions-of-people/?utm_source=rss&utm_medium=rss&utm_campaign=innovative-medicines-too-damn-expensive-health-risk-for-billions-of-people http://www.tapanray.in/innovative-medicines-too-damn-expensive-health-risk-for-billions-of-people/#comments Mon, 18 Mar 2019 00:00:22 +0000 Tapan Ray http://www.tapanray.in/?p=9448 Continue reading →]]> http://www.tapanray.in/innovative-medicines-too-damn-expensive-health-risk-for-billions-of-people/feed/ 0 Data: The New ‘Magic Wand’ For Pharma Business Excellence? http://www.tapanray.in/data-the-new-magic-wand-for-pharma-business-excellence/?utm_source=rss&utm_medium=rss&utm_campaign=data-the-new-magic-wand-for-pharma-business-excellence http://www.tapanray.in/data-the-new-magic-wand-for-pharma-business-excellence/#comments Mon, 01 Oct 2018 00:00:46 +0000 Tapan Ray http://www.tapanray.in/?p=9166 Continue reading →]]> http://www.tapanray.in/data-the-new-magic-wand-for-pharma-business-excellence/feed/ 0 Big Pharma Demands Transparency, Keeping their ‘Black-Boxes’ Tight and Safe? http://www.tapanray.in/big-pharma-demands-transparency-keeping-their-black-boxes-tight-and-safe/?utm_source=rss&utm_medium=rss&utm_campaign=big-pharma-demands-transparency-keeping-their-black-boxes-tight-and-safe http://www.tapanray.in/big-pharma-demands-transparency-keeping-their-black-boxes-tight-and-safe/#comments Mon, 28 Oct 2013 00:00:21 +0000 Tapan Ray http://www.tapanray.in/?p=2780 Continue reading →]]> http://www.tapanray.in/big-pharma-demands-transparency-keeping-their-black-boxes-tight-and-safe/feed/ 0 Transparency in Drug Trial Data: Thwarted by Lobbyists or Embroiled in Controversy? http://www.tapanray.in/transparency-in-drug-trial-data-thwarted-by-lobbyists-or-embroiled-in-controversy/?utm_source=rss&utm_medium=rss&utm_campaign=transparency-in-drug-trial-data-thwarted-by-lobbyists-or-embroiled-in-controversy http://www.tapanray.in/transparency-in-drug-trial-data-thwarted-by-lobbyists-or-embroiled-in-controversy/#comments Mon, 05 Aug 2013 00:00:22 +0000 Tapan Ray http://www.tapanray.in/?p=3274 Continue reading →]]> http://www.tapanray.in/transparency-in-drug-trial-data-thwarted-by-lobbyists-or-embroiled-in-controversy/feed/ 0 Pioglitazone Conundrum: Should The Drug Regulator Step Over The Line? http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/?utm_source=rss&utm_medium=rss&utm_campaign=pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/#comments Mon, 08 Jul 2013 00:00:54 +0000 Tapan Ray http://www.tapanray.in/?p=2883 Continue reading →]]> http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/feed/ 0 To Curb Pharma Marketing Malpractices in India Who Bells the Cat? http://www.tapanray.in/to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat/?utm_source=rss&utm_medium=rss&utm_campaign=to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat http://www.tapanray.in/to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat/#comments Mon, 18 Mar 2013 00:00:37 +0000 Tapan Ray http://www.tapanray.in/?p=2050 Continue reading →]]> http://www.tapanray.in/to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat/feed/ 0 Does India need an equivalent of ‘The Physician Payment Sunshine Act’ of the US for transparency in pharmaceutical marketing? http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/?utm_source=rss&utm_medium=rss&utm_campaign=does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/#comments Mon, 14 Nov 2011 00:00:41 +0000 Tapan Ray http://tapanray.in/index.php/?p=175 Continue reading →]]> http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/feed/ 0